Correction of the company's capital loan and information disclosure schedule from Jan. to Mar. 2022

 Correction of the company's capital loan and
information disclosure schedule from Jan. to Mar. 2022

1.Date of occurrence of the event:2022/05/17
2.Company name:SOFIVA GENOMICS CO., LTD.
3.Relationship to the Company (please enter "head
  office" or  "subsidiaries"):head office
4.Reciprocal shareholding ratios:N/A
5.Cause of occurrence:Correction of the company's capital
loan and information disclosure schedule from January to
March 2022
6.Information items/ statements to be corrected:
Fund loan and information disclosure schedule
7.Amounts/ contents/ number of page to be corrected:
Accumulated in Jan. 2022 to the highest balance of the
month：NT$20,033 thousands.
Ending balance of Jan. 2022：NT$15,025 thousands.
Actual amount borrowed of Jan. 2022：NT$7,512 thousands.
Accumulated in Feb. 2022 to the highest balance of the
month：NT$15,590 thousands.
Ending balance of Feb. 2022：NT$15,590 thousands.
Accumulated in Mar. 2022 to the highest balance of the
month：NT$15,572 thousands.
Ending balance of Mar. 2022：NT$15,572 thousands.
8.Amounts/ contents/ number of page after correction:
Accumulated in Jan. 2022 to the highest balance of the
month：NT$10,073 thousands.
Ending balance of Jan. 2022：NT$10,073 thousands.
Actual amount borrowed of Jan. 2022：NT$7,555 thousands.
Accumulated in Feb. 2022 to the highest balance of the
month：NT$10,393 thousands.
Ending balance of Feb. 2022：NT$10,393 thousands.
Accumulated in Mar. 2022 to the highest balance of the
month：NT$10,381 thousands.
Ending balance of Mar. 2022：NT$10,381 thousands.
9.Countermeasures:Re-upload to the Market Observation Post
System (MOPS) after correction
10.Any other matters that need to be specified:None.